145 related articles for article (PubMed ID: 31034031)
1. Absence of K13 gene mutations among artesunate/sulfadoxine-pyrimethamine treatment failures of Sudanese Plasmodium falciparum isolates from Damazin, southeast Sudan.
Abdel Hamid MM; Abdallah WME; Hussien M; Mohammed NM; Malik EM; Ahmed ME; Mohamed AO
Trans R Soc Trop Med Hyg; 2019 Jul; 113(7):428-430. PubMed ID: 31034031
[TBL] [Abstract][Full Text] [Related]
2. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.
Awab GR; Imwong M; Pukrittayakamee S; Alim F; Hanpithakpong W; Tarning J; Dondorp AM; Day NP; White NJ; Woodrow CJ
Malar J; 2016 Feb; 15():121. PubMed ID: 26917051
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
[TBL] [Abstract][Full Text] [Related]
5. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Adeel AA; Elnour FA; Elmardi KA; Abd-Elmajid MB; Elhelo MM; Ali MS; Adam MA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
Malar J; 2016 May; 15(1):285. PubMed ID: 27209063
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
[TBL] [Abstract][Full Text] [Related]
7. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
[TBL] [Abstract][Full Text] [Related]
8. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
Gadalla NB; Abdallah TM; Atwal S; Sutherland CJ; Adam I
Malar J; 2013 Jul; 12():255. PubMed ID: 23870667
[TBL] [Abstract][Full Text] [Related]
9. Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.
Mohamed AO; Abdel Hamid MM; Mohamed OS; Elkando NS; Suliman A; Adam MA; Elnour FAA; Malik EM
Malar J; 2017 Apr; 16(1):163. PubMed ID: 28427409
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
[TBL] [Abstract][Full Text] [Related]
12. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
Elamin SB; Malik EM; Abdelgadir T; Khamiss AH; Mohammed MM; Ahmed ES; Adam I
Malar J; 2005 Sep; 4():41. PubMed ID: 16162284
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
14. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
Tjitra E; Suprianto S; Currie BJ; Morris PS; Saunders JR; Anstey NM
Am J Trop Med Hyg; 2001 Oct; 65(4):309-17. PubMed ID: 11693875
[TBL] [Abstract][Full Text] [Related]
15. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Ibrahium AM; Kheir MM; Osman ME; Khalil IF; Alifrangis M; Elmardi KA; Malik EM; Adam I
Ann Trop Med Parasitol; 2007 Jan; 101(1):15-21. PubMed ID: 17244406
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Adam I; A-Elbasit IE; Idris SM; Malik EM; Elbashir MI
Ann Trop Med Parasitol; 2005 Jul; 99(5):449-55. PubMed ID: 16004704
[TBL] [Abstract][Full Text] [Related]
17. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
18. No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo.
Mayengue PI; Niama RF; Kouhounina Batsimba D; Malonga-Massanga A; Louzolo I; Loukabou Bongolo NC; Macosso L; Ibara Ottia R; Kimbassa Ngoma G; Dossou-Yovo LR; Pembet Singana B; Ahombo G; Sekangue Obili G; Kobawila SC; Parra HJ
BMC Infect Dis; 2018 Oct; 18(1):538. PubMed ID: 30373565
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial.
Allen EN; Little F; Camba T; Cassam Y; Raman J; Boulle A; Barnes KI
Malar J; 2009 Jun; 8():141. PubMed ID: 19558654
[TBL] [Abstract][Full Text] [Related]
20. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
